Skip to main content
Log in

Special expression of Thy-1 in different malignant tumors

  • Original Article
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective

To investigate the expression status of Thy-1 in malignant cancerous tissues and to evaluate whether Thy-1 could be a potential tumor marker.

Methods

Immunohistochemistry method was used to examine Thy-1 expressions in different malignant tumor tissues. We used a monoclonal antibody specific for Thy-1 and the indirect Catalysis Signal Amplification method. With the help of tissue microarray (TMA), we examined expression the status of Thy-1 in 1451 different types of malignant tumor tissues, 144 normal tissues and benign lesions.

Results

All the malignant tumor cells were grouped as one group (malignant cells group) and normal or benign tumor tissue cells as another group (normal cells group). Among the entire 1451 malignant cases group, positive Thy-1 expression with diffuse and strong staining was observed in 734 (734/1451; 50.59%) cases. In the benign cases only 6 chronic cervicitis cases showed weak staining for Thy-1. All the normal tissue showed negative staining. One-way ANVOA analysis showed F value between these two groups was 147.229 (P<0.0001).

Conclusion

A significantly stronger expression of Thy-1 in malignant tumors was observed. Special overexpression of Thy-1 in malignant tumors suggests that Thy-1 might be a potential novel tumor marker with respect to cancer progression. Chronic cervicitis has some relationship with cervix carcinoma. When it develops into atypical hyperplasia, it will be a precancerous lesion for cervix carcinoma. In this research we found weak staining for Thy-1 in chronic cervicitis lesion, so Thy-1 may play a crucial role in carcinogenesis for cervix carcinoma. The research about the relationship between Thy-1 expressions in cancer cells and in precancerous lesion will provide some clues to understand the mechanism for carcinogenesis process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leyton L, Schneider P, Labra CV, et al. Thy-1 binds to integrin beta(3) on astrocytes and triggers formation of focal contact sites [J]. Curr Biol 2001; 11:1028–1038.

    Article  CAS  PubMed  Google Scholar 

  2. Reif AE, Allen JM. The AKR thymic antigen and its distribution in leukemias and nervous tissues [J]. J Exp Med 1964; 120:413–433.

    Article  CAS  PubMed  Google Scholar 

  3. Dalchau R, Fabre JW. Identification and unusual tissue distribution of the canine and human homologues of Thy-1 (theta) [J]. J Exp Med 1979; 149:576–591.

    Article  CAS  PubMed  Google Scholar 

  4. Koumas L, Smith TJ, Feldon S, et al. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes [J]. Am J Pathol 2003; 163:1291–1300.

    CAS  PubMed  Google Scholar 

  5. Rege TA, Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis [J]. Faseb J 2006; 20: 1045–1054.

    Article  CAS  PubMed  Google Scholar 

  6. Rege TA, Hagood JS. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses [J]. Biochim Biophys Acta 2006; 1763:991–999.

    Article  CAS  PubMed  Google Scholar 

  7. Saalbach A, Wetzel A, Haustein UF, et al. Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium [J]. Oncogene 2005; 24: 4710–4720.

    Article  CAS  PubMed  Google Scholar 

  8. Zeng LQ, Peng ZL. Growth inhibitory effects of THY1 gene on epithelial ovarian cancer SKOV3 cells [J]. Nan Fang Yi Ke Da Xue Xue Bao (in Chinese) 2007; 27:84–87, 91.

    Google Scholar 

  9. Chen JF, et al. Abnormal expression of Thy-1 as a novel tumor marker in lung cancer and its prognostic significance [J]. Zhonghua Yi Xue Za Zhi (in Chinese) 2005; 85:1921–1925.

    CAS  Google Scholar 

  10. McKenzie JL, Dalchau R, Fabre JW. Biochemical characterisation and localization in brain of a human brain-leucocyte membrane glycoprotein recognised by a monoclonal antibody [J]. J Neurochem 1982; 39:1461–1466.

    Article  CAS  PubMed  Google Scholar 

  11. Reif AE, Allen JM. Mouse nervous tissue iso-antigens [J]. Nature 1966; 209:523.

    Article  CAS  PubMed  Google Scholar 

  12. Rege TA, Pallero MA, Gomez C, et al. Thy-1, via its GPI anchor, modulates Src family kinase and focal adhesion kinase phosphorylation and subcellular localization, and fibroblast migration, in response to thrombospondin-1/hep I [J]. Exp Cell Res 2006; 312:3752–3767.

    Article  CAS  PubMed  Google Scholar 

  13. Wang X, Wiesinger J, Beard J, et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome [J]. J Neurol Sci 2004; 220:59–66.

    Article  CAS  PubMed  Google Scholar 

  14. He HT, Naquet P, Caillol D, et al. Thy-1 supports adhesion of mouse thymocytes to thymic epithelial cells through a Ca2(+)-independent mechanism [J]. J Exp Med 1991; 173:515–518.

    Article  CAS  PubMed  Google Scholar 

  15. Hueber AO, Raposo G, Pierres M, et al. Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism [J]. J Exp Med 1994; 179:785–796.

    Article  CAS  PubMed  Google Scholar 

  16. Mason JC, Yarwood H, Tárnok A, et al. Human Thy-1 is cytokine-inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C [J]. J Immunol 1996; 157:874–883.

    CAS  PubMed  Google Scholar 

  17. Haeryfar SM, Hoskin DW. Thy-1: more than a mouse pan-T cell marker [J]. J Immunol 2004; 173:3581–3588.

    CAS  PubMed  Google Scholar 

  18. Saalbach A, Arnhold J, Lessig J, et al. Human Thy-1 induces secretion of matrix metalloproteinase-9 and CXCL8 from human neutrophils [J]. Eur J Immunol 2008; 38: 1391–1403.

    Article  CAS  PubMed  Google Scholar 

  19. Abeysinghe HR, Cao Q, Xu J,et al. THY1 expression is associated with tumor suppression of human ovarian cancer [J]. Cancer Genet Cytogenet 2003; 143:125–132.

    Article  CAS  PubMed  Google Scholar 

  20. Lung HL, Bangarusamy DK, Xie D,et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma [J]. Oncogene 2005; 24:6525–6532.

    CAS  PubMed  Google Scholar 

  21. Abeysinghe HR, Pollock SJ, Guckert NL, et al. The role of the THY1 gene in human ovarian cancer suppression based on transfection studies [J]. Cancer Genet Cytogenet 2004; 149:1–10.

    Article  CAS  PubMed  Google Scholar 

  22. Saalbach A, Hildebrandt G, Haustein UF, et al. The Thy-1/Thy-1 ligand interaction is involved in binding of melanoma cells to activated Thy-1-positive microvascular endothelial cells [J]. Microvasc Res 2002; 64: 86–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yue Yang.

Additional information

This work was supported by a grant from the Foundation of Health Bureau of Beijing (No.2003-049)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Jf., Lu, Ap., Wu, N. et al. Special expression of Thy-1 in different malignant tumors. Chin. J. Cancer Res. 22, 73–79 (2010). https://doi.org/10.1007/s11670-010-0073-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-010-0073-0

Key words

CLC number

Navigation